VLCD for weight loss and remission of type 2 diabetes? - Authors' reply

Affiliations

¹ Newcastle Magnetic Resonance Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. Electronic address: roy.taylor@ncl.ac.uk.
² Human Nutrition Research Centre, Institute of Health and Society, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.
³ Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK; Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.
⁴ Human Nutrition, School of Medicine, Dentistry, and Nursing, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, UK.
⁵ Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.

Comment

Roy Taylor et al. Lancet. 2018.

. 2018 Oct 13;392(10155):1307.

doi: 10.1016/S0140-6736(18)31892-0.

¹ Newcastle Magnetic Resonance Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. Electronic address: roy.taylor@ncl.ac.uk.
² Human Nutrition Research Centre, Institute of Health and Society, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.
³ Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK; Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.
⁴ Human Nutrition, School of Medicine, Dentistry, and Nursing, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, UK.
⁵ Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.

No abstract available

Comment on

VLCD for weight loss and remission of type 2 diabetes?
Ahmad N, Alfaris N. Ahmad N, et al. Lancet. 2018 Oct 13;392(10155):1306-1307. doi: 10.1016/S0140-6736(18)31889-0. Lancet. 2018. PMID: 30322573 No abstract available.